{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-24-059689","form_type":"8-K","ticker":"LCTX","cik":"0000876343","company_name":"Lineage Cell Therapeutics, Inc.","filed_at":"2024-05-14T23:59:59+00:00","discovered_at":"2026-05-14T18:03:22.249660+00:00","generated_at":"2026-06-02T01:38:46.735545+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Lineage Cell Therapeutics files $40M ATM equity offering via B. Riley","bullets":["Prospectus supplement filed May 14, 2024 to sell up to $39,966,424 of common shares at-the-market.","Sales agent is B. Riley Securities, Inc. under agreement dated March 22, 2024.","Shares offered pursuant to effective shelf registration statement (File No. 333-277758).","Legal opinion from Sheppard Mullin on share legality included as exhibit."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-24-059689","json":"https://secwatch.observer/filing/0000950170-24-059689.json","markdown":"https://secwatch.observer/filing/0000950170-24-059689.md","text":"https://secwatch.observer/filing/0000950170-24-059689.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/876343/000095017024059689/0000950170-24-059689-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/876343/000095017024059689/lctx-20240514.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-02T01:38:46.735545+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}